+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Urology Laser Market - Growth, Trends, and Forecast (2020 - 2025)

  • ID: 4997427
  • Report
  • March 2020
  • Region: Global
  • 112 pages
  • Mordor Intelligence
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now


  • Allengers
  • Biolitec AG
  • Cook Group
  • El.En. Group
  • Lumenis
  • Medtronic
  • MORE
The Urology Laser Market is expected to register a CAGR of 5.7% during the forecast period. The key factors bolstering the market growth include high incidence of urologic conditions, growing acceptance for minimally invasive treatment and technological advancements.

Rising adoption of minimally invasive surgical procedures in holmium systems as well as thulium laser treatment systems is one of the major factors propelling the market for urology lasers. These systems offer several benefits, such as greater efficiency, safety, and rapid recovery, resulting in increased demand for thulium and holmium systems. Furthermore, laser procedure provides benefits such as faster recovery, shorter hospital stays, decreased blood loss and lower overall body pain resulting from smaller incisions. Hence the reliability and safety features of these systems are expected to drive market growth.

The high incidence rates and health complications coupled with urological diseases is propelling the market of urology laser market. According to the American Urological Association Foundation, urinary incontinence, urinary tract infections, benign prostatic hyperplasia and lower urinary tract symptoms are among the most common urological diseases. In addition, increasing prevalence of urinary tract infection will drive the market in upcoming year. According to the World Health Organization, approximately 50% of women suffer from UTI at some point in their lives.

Moreover, advent in technology will propel the growth of the urology laser market. For instance, GreenLight HPS Laser Therapy System by Boston Scientific Corporation that uses the 10-2090 fiber for the treatment of Benign Prostatic Hyperplasia (BPH) as well as EA fiber for the treatment of urethral strictures and bladder tumors in patients. However, high cost associated with laser devices can impede the proliferation of laser technologies.

Key Market Trends

Benign prostatic hyperplasia (BPH) is Expected to Hold the Largest Revenue in the Segment in Urology Laser Market
  • The segment benign prostatic hyperplasia is expected to dominate the market during the forecast period due to increase in the prevalence of urological disorders. It is predominant among African males because of the high testosterone levels, 5-alpha-reductase activity and androgen receptor expression. At least 50% of men aged 40 and older have BPH.
  • By application, urolithiasis is projected to be one of the rapidly growing segments over the forecast period due to a rising number of patients suffering from stony concretions in bladder and urinary tract. Improper sanitation facilities, high consumption of caffeine and adoption of unhealthy lifestyles are the key factor driving the market over the forecast period. Thus, rising patient pool suffering from urinary tract stones, kidney stones and bladder stones are expected to drive the demand for urology lasers for effective treatment.
  • In addition, holmium laser type segment held a maximum share in the urology laser market owing to its minimally invasive surgical technique as well as special modalities. Furthermore, holmium laser systems is considered as the safest and effective technique for treating urological disorders as it offers several advantages such as lower rate of bleeding and quick as well as safe procedure requiring fewer incisions. These factors are expected to drive the demand for urology lasers.
  • By laser type, thulium segment hold a significant market share in the urology laser market and is anticipated to show similar trend over the forecast period due to benefits over traditional transurethral resection method which may helps in protecting against significant blood loss.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America currently dominates the market for urology laser devices and is expected to continue its stronghold for a few more years owing to the increasing prevalence of urolithiasis, BPH and other urology-related disorders. According to National Center for Biotechnology Information, approximately 70 percent of adult experience BPH at some point in their lifetimes in the United States. Technological advancements in urology laser equipment play a vital role in driving the demand for urology lasers. For instance, in May 2018, Olympus launched EMPOWER laser portfolio line in order to deliver full range of capabilities in Ho: YAG lithotripsy specialized in fragmentation, dusting, and soft tissue ablation. The benefits of EMPOWER solutions include greater dusting capability, greater versatility, a stabilization mode, etc.

Competitive Landscape

The urology laser market consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Olympus Corporation, Boston Scientific Corporation, Richard Wolf GmbH, Cook Group, Medtronic, biolitec AG and Lumenis Ltd. For instance, Boston Scientific Corporation introduced its advanced GreenLight HPS Laser Therapy System for an effective and safe treatment for urethral strictures and bladder tumors. Advancements such as these are anticipated to boost the market growth over the forecast period.

Reasons to Purchase this report:
  • The market estimate (ME) sheet in Excel format.
  • 3 months of analyst support.

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 5


  • Allengers
  • Biolitec AG
  • Cook Group
  • El.En. Group
  • Lumenis
  • Medtronic
  • MORE
1.1 Study Assumptions
1.2 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Increase in Prevalence of Urological Disorders
4.2.2 Technological Advancements
4.2.3 Rising Demand for Minimally Invasive Surgical Procedures
4.3 Market Restraints
4.3.1 High Cost of Laser System
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Laser Type
5.1.1 Holmium Laser System
5.1.2 Diode Laser Systems
5.1.3 Thulium Laser System
5.1.4 Others
5.2 By Application
5.2.1 Benign Prostatic Hyperplasia
5.2.2 Urolithiasis
5.2.3 Non-Muscle-Invasive Bladder Cancer
5.2.4 Others
5.3 Geography
5.3.1 North America United States Canada Mexico
5.3.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.3.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.3.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.3.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 Allengers
6.1.2 Biolitec AG
6.1.3 Boston Scientific Corporation
6.1.4 Cook Group
6.1.5 El.En. Group
6.1.6 Lumenis
6.1.7 Medtronic
6.1.8 Olympus Corporation
6.1.9 OmniGuide Holdings, Inc
6.1.10 Richard Wolf GmbH
6.1.11 Surgical Lasers Inc.

Note: Product cover images may vary from those shown
3 of 5


4 of 5
  • Allengers
  • Biolitec AG
  • Boston Scientific Corporation
  • Cook Group
  • El.En. Group
  • Lumenis
  • Medtronic
  • Olympus Corporation
  • OmniGuide Holdings, Inc
  • Richard Wolf GmbH
  • Surgical Lasers Inc.
Note: Product cover images may vary from those shown
5 of 5